Ronald A. Pepin
Corporate Officer/Principal at CELLDEX THERAPEUTICS, INC.
Net worth: - $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Anthony Marucci | M | 62 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 41 years |
Sam Martin | M | 53 | 15 years | |
Tibor Keler | M | 65 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 41 years |
Sarah Boylan Cavanaugh | F | 49 | 12 years | |
Karen Shoos | F | 70 | 23 years | |
Herbert Conrad | M | 91 | 16 years | |
Rita Jain | M | 62 | 1 years | |
Keith Brownlie | M | 71 | 7 years | |
Sandra Leung | F | 63 | 32 years | |
Garry Neil | M | 70 | 2 years | |
James Marino | M | 74 | 7 years | |
Harry Penner | M | 78 | 27 years | |
Cheryl Cohen | F | 58 | 2 years | |
Ursula B. Bartels | F | 66 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 17 years |
Lee Eppstein | M | 81 |
Antyra, Inc.
Antyra, Inc. Pharmaceuticals: MajorHealth Technology Antyra, Inc. develops cancer therapeutics. Its products include lead programs, a program to generate and develop disease-specific therapeutics; oncology leads, such as IGF-1R Antagonist, which represent a clinical strategy for the treatment of pancreatic and other cancers; and ANT-G12, a technology that isolates cytotoxic peptimetics that bind to cell surface targets expressed in a disease-specific context. The company was founded by by John K. A. Prendergast and Arthur J. Blume in 1996 and is headquartered in Edison, NJ. | - |
Elizabeth Crowley | F | 52 | 15 years | |
Richard Wright | M | 60 | 12 years | |
Diane Young | M | 68 | 5 years | |
Margo Heath-Chiozzi | M | 67 | 7 years | |
Freddy Jimenez | M | 55 | 8 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Giovanni Caforio | M | 59 | 24 years | |
Avery Catlin | M | 75 | 17 years | |
Lamberto Andreotti | M | 73 | 19 years | |
Donald Lee Drakeman | M | 70 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 19 years |
Howard H. Pien | M | 66 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 2 years |
Priya Jambhekar | F | - | 3 years | |
Thomas Andrew Davis | M | 60 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 14 years |
Leif Valdemar Johansson | M | 73 | 13 years | |
Lewis B. Campbell | M | 77 | 18 years | |
Christian Schade | M | 63 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 9 years |
Laurie Glimcher | M | 72 | 20 years | |
Scott Coiante | M | 57 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 8 years |
Michael W. Fanger | M | 84 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 17 years |
Fouad Namouni | M | 55 | 21 years | |
Lawrence Hamilton | M | 66 | 8 years | |
Anthony Hooper | M | 69 | 15 years | |
John E. Elicker | M | 64 | 20 years | |
Charles Sigal | M | 72 | 16 years | |
Brian Daniels | M | 65 | 14 years | |
George Elston | M | 59 | 9 years | |
Gerald Bruce | M | 68 | 8 years | |
Steven B. Ratoff | M | 81 | 16 years | |
Richard van den Broek | M | 57 | 2 years | |
Shu Hui Chen | M | 61 | 5 years | |
Kenneth E. Lebioda | M | - | 5 years | |
Mitchell P. Cybulski | M | 77 | 6 years | |
Lie Ping Chen | M | - | - | |
Rebecca Taub | M | 71 | 3 years | |
Peter S. Linsley | M | 72 | 14 years | |
James New | M | 70 | 12 years | |
Zola P. Horovitz | M | 89 | - | |
Beth Anne Piper | M | - | 4 years | |
Laurie Alsup | M | 70 | 10 years | |
Larry K. Benedict | M | 63 | 7 years | |
Kenneth F. Anderson | M | - | 17 years | |
Miguel Forte | M | 63 | 5 years | |
Lucius Allen | M | - | - | |
Paul Herbert Chew | M | 72 | 9 years | |
Fu-Min Su | M | - | 6 years | |
James G. Stout | M | 58 |
Medarex, Inc.
Medarex, Inc. Miscellaneous Commercial ServicesCommercial Services Medarex, Inc. provides commercial physical and biological research services. The company's UltiMAb, a human antibody development system creates and develops antibodies products for cancer, rheumatoid arthritis, inflammatory, autoimmune, and infectious diseases. The company was founded in 1987 and is headquartered in Princeton, New Jersey. | 1 years |
Arturo O. Araya | M | 53 | 3 years | |
John H. Lawrence | M | - | 18 years | |
Kevin McManus | M | - | 9 years | |
Yadagiri R Pendri | M | 68 | 7 years | |
Benjamin Winograd | M | 63 | 9 years | |
debra j bass | M | - | 2 years | |
Richard Colonno | M | 74 | 16 years | |
Andrew Bodnar | M | 75 | - | |
Jane A. Kramer | F | 68 | 11 years | |
Helen Torley | M | 61 | 5 years | |
Richard J. White | M | 82 | 12 years | |
Gregory A. Fischer | M | - | 12 years | |
Timothy P. Cost | M | 65 | 5 years | |
Beth Seidenberg | M | 67 | 2 years | |
Steven E. Benner | M | 64 | 7 years | |
John L. McGoldrick | M | 83 | 10 years | |
James G. Ham | M | 74 | 7 years | |
William Jones | M | 60 | 12 years | |
Timothy McNamara | M | 67 | 9 years | |
Kevin Rooney | M | 58 | 6 years | |
Anthony A. McBride | M | 60 | - | |
Daniel M. Bollag | M | 63 | 2 years | |
Phillip John Brancazio | M | 71 | 23 years | |
Luigi Lenaz | M | 83 | 19 years | |
David E. Martin | M | 57 | 2 years | |
Julius A. Vida | M | 95 | 18 years | |
Stephen Sadove | M | 72 | 10 years | |
William R. Miller | M | 95 | 27 years | |
Barry Wilson | M | 80 | 13 years | |
Robert A. Ashley | M | 66 | 5 years | |
Daniel Lynch | M | 65 | 15 years | |
Walter R. Maupay | M | 84 | - | |
Robert L. Simon | M | 79 | 13 years | |
N. Coles | M | 63 | - | |
Stephen K. Carter | M | 85 | 13 years | |
Rick Winningham | M | 64 | 4 years | |
Marino Carol | F | - | 8 years | |
Rajesh K. Malik | M | 65 | 2 years | |
Gary Dickinson | M | 72 | 4 years | |
Robert Jones | M | - | 3 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Ronald A. Pepin
- Personal Network